• Bharat Forge – Signs MoU with VVDN Technologies for strategic solutions across automotive, defence & data centre markets.
• DCX Systems – Secures combined orders worth ₹45.4 crore for cable & PCB assemblies.
• Tejas Networks – Receives ₹69.97 crore under PLI scheme from Ministry of Communications.
• Lumax Auto Technologies – NCLT approves amalgamation with IAC International Automotive.
• BL Kashyap and Sons – Bags ₹300 crore civil construction order from CRC Greens.
• DLF – NCLT Chandigarh approves merger of eight arms with Highvista Buildcon.
• NCC Limited – Debarred by NHAI from bidding for two years.
• Omaxe – Arm receives RERA approvals for two Faridabad projects.
• Prestige Estates Projects – Acquires 100% stake in Aspire Spaces Tellapur.
• Cochin Shipyard – Signs ₹2,000+ crore contract with CMA CGM, France for six feeder container vessels.
• Zydus Lifesciences – US FDA approval for Bosentan tablets.
• Dr. Reddy’s Laboratories – Signs $32.15 million pact to acquire Progynova & CycloProgynova trademarks.
• Hindustan Unilever (HUL) – Approves ₹2,000 crore capex to expand Beauty & Wellbeing & Home Care manufacturing.
• Kajaria Ceramics – Acquires remaining 25% in Kajaria Adhesive; now wholly-owned subsidiary.
• Intellect Design Arena – Launches AI-first banking platform “eMACH.ai.”
• Tatva Chintan Pharma Chem – Signs renewable power purchase pact in Gujarat.
• GNG Electronics – Enters pan-India distribution pact for refurbished computers.
• Mufin Green Finance – Receives approval for preferential allotment & warrants issuance.
• Yatra Online – Promoter sells 1.8% stake via open market.
• TIL Limited – Board to consider fundraise via QIP/rights issue on Feb 23.
• Pace Digitek – Secures $1.35 million export order for mobile battery systems.
• Bharat Electronics (BEL) – Board to consider second interim dividend on Feb 27.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.
